StonvexLoading…
StonvexStonvexStonvexCore line items from PL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $307.73M | $244.35M | $220.70M | $191.26M |
Operating Income | $-95.07M | $-116.12M | $-169.75M | $-175.68M |
Net Income | $-246.86M | $-123.20M | $-140.51M | $-161.97M |
EPS (Diluted) | $-0.80 | $-0.42 | $-0.50 | $-0.61 |
Total Assets | $1.15B | $633.80M | $702.00M | $752.72M |
Total Liabilities | $957.25M | $192.51M | $183.98M | $176.62M |
Cash & Equivalents | $229.44M | $118.05M | $83.87M | $181.89M |
Free Cash Flow OCF − CapEx | $57.65M | $-58.67M | $-88.70M | $-84.37M |
Shares Outstanding | 307.80M | 292.12M | 279.59M | 267.13M |